{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T18:43:16Z","timestamp":1784745796888,"version":"3.55.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002713","name":"Imam Mohammed Ibn Saud Islamic University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023673","name":"Imam Mohammed Ibn Saud Islamic University Deanship of Scientific Research","doi-asserted-by":"publisher","award":["IMSIU-DDRSP2501"],"award-info":[{"award-number":["IMSIU-DDRSP2501"]}],"id":[{"id":"10.13039\/501100023673","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.bmc.2025.118451","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T14:43:52Z","timestamp":1761403432000},"page":"118451","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Pharmacophore-based high-throughput virtual screening (HTVS) to identify new c-Src kinase inhibitors with anticancer potential"],"prefix":"10.1016","volume":"132","author":[{"given":"Ali M.","family":"Alaseem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Summya","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Puneetha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Arockia","family":"Babu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glowi","family":"Alasiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thakur Gurjeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogita","family":"Tyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Suhail","family":"Akhter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand Mohan","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2025.118451_bb0005","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0014-5793(95)00580-3","article-title":"Protein kinases\u2014structure and function","volume":"369","author":"Bossemeyer","year":"1995","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bmc.2025.118451_bb0010","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3390\/cancers10030063","article-title":"Kinases and cancer","volume":"10","author":"Cicenas","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bmc.2025.118451_bb0015","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.cell.2010.06.011","article-title":"Cell signaling by receptor tyrosine kinases","volume":"141","author":"Lemmon","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bmc.2025.118451_bb0020","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.bbrc.2010.07.092","article-title":"RAF protein-serine\/threonine kinases: structure and regulation","volume":"399","author":"Roskoski","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bmc.2025.118451_bb0025","first-page":"4729","article-title":"Promising targets in anti-cancer drug development: recent updates","volume":"24","author":"Kumar","year":"2017","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bmc.2025.118451_bb0030","series-title":"Current molecular targets of heterocyclic compounds for cancer therapy","first-page":"115","article-title":"Cyclin-dependent Kinase 4 and 6 in cancer: exploration of CDK4\/6 inhibitors as anticancer agents","author":"Nandi","year":"2024"},{"key":"10.1016\/j.bmc.2025.118451_bb0035","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jsps.2020.03.002","article-title":"Liraglutide attenuates gefitinib-induced cardiotoxicity and promotes cardioprotection through the regulation of MAPK\/NF-\u03baB signaling pathways","volume":"28","author":"AlAsmari","year":"2020","journal-title":"Saudi Pharmaceut J"},{"key":"10.1016\/j.bmc.2025.118451_bb0040","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.phrs.2019.01.039","article-title":"Targeting ERK1\/2 protein-serine\/threonine kinases in human cancers","volume":"142","author":"Roskoski","year":"2019","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.bmc.2025.118451_bb0045","doi-asserted-by":"crossref","first-page":"S417","DOI":"10.1097\/01.CCM.0000191714.39495.A6","article-title":"Mitogen-activated protein kinase (MAPK)","volume":"33","author":"Cuschieri","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1016\/j.bmc.2025.118451_bb0050","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1091\/mbc.10.4.891","article-title":"Microdomain-dependent regulation of Lck and Fyn protein-tyrosine kinases in T lymphocyte plasma membranes","volume":"10","author":"Ilangumaran","year":"1999","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.bmc.2025.118451_bb0055","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2316467120","article-title":"Membrane-bound Merkel cell polyomavirus middle T protein constitutively activates PLC\u03b31 signaling through Src-family kinases","volume":"120","author":"Peng","year":"2023","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bmc.2025.118451_bb0060","doi-asserted-by":"crossref","unstructured":"Beltran A., Faure A.J., Lehner B. The allosteric landscape of the Src kinase. bioRxiv. 2024. (Preprint posted on bioRxiv)https:\/\/doi.org\/10.1101\/2024.04.26.591297.","DOI":"10.1101\/2024.04.26.591297"},{"key":"10.1016\/j.bmc.2025.118451_bb0065","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.chembiol.2023.08.005","article-title":"Profiling of drug resistance in Src kinase at scale uncovers a regulatory network coupling autoinhibition and catalytic domain dynamics","volume":"31","author":"Chakraborty","year":"2024","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.bmc.2025.118451_bb0070","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1021\/acs.biochem.4c00323","article-title":"Cocrystallization of the Src-family kinase Hck with the ATP-site inhibitor A-419259 stabilizes an extended activation loop conformation","volume":"63","author":"Selzer","year":"2024","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmc.2025.118451_bb0075","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.bbrc.2004.09.171","article-title":"Src protein\u2013tyrosine kinase structure and regulation","volume":"324","author":"Roskoski","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bmc.2025.118451_bb0080","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bbapap.2007.08.012","article-title":"Src family kinases: regulation of their activities, levels and identification of new pathways","volume":"1784","author":"Ingley","year":"2008","journal-title":"Biochim Biophys Acta (BBA)-Proteins Proteom"},{"key":"10.1016\/j.bmc.2025.118451_bb0085","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/path.6264","article-title":"Serine\/threonine-protein kinase D2-mediated phosphorylation of DSG2 threonine 730 promotes esophageal squamous cell carcinoma progression","volume":"263","author":"Liu","year":"2024","journal-title":"J Pathol"},{"key":"10.1016\/j.bmc.2025.118451_bb0090","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jmgm.2006.08.008","article-title":"Discovery of new potent human protein tyrosine phosphatase inhibitors via pharmacophore and QSAR analysis followed by in silico screening","volume":"25","author":"Taha","year":"2007","journal-title":"J Mol Graph Model"},{"key":"10.1016\/j.bmc.2025.118451_bb0095","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/ijms21010019","article-title":"Use of QSAR global models and molecular docking for developing new inhibitors of c-src tyrosine kinase","volume":"21","author":"Ancuceanu","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2025.118451_bb0100","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1021\/jm0496077","article-title":"Neamati, \u03b2-Diketo acid pharmacophore hypothesis. 1. Discovery of a novel class of HIV-1 integrase inhibitors","volume":"48","author":"Dayam","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118451_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2024.110019","article-title":"A structure-based pharmacophore modelling approach to identify and design new neprilysin (NEP) inhibitors: an in silico-based investigation","volume":"756","author":"Thakur","year":"2024","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.bmc.2025.118451_bb0110","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1747-0285.2006.00384.x","article-title":"PHASE: a novel approach to pharmacophore modeling and 3D database searching","volume":"67","author":"Dixon","year":"2006","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.bmc.2025.118451_bb0115","article-title":"Computational analysis of phase I metabolism in clinically studied Flavoalkaloids: molecular docking, MMGBSA binding energy calculations, and molecular dynamics simulations","volume":"9","author":"Kallurkar","year":"2024","journal-title":"ChemistrySelects"},{"key":"10.1016\/j.bmc.2025.118451_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-4682-10-63","article-title":"Molecular docking studies for the identification of novel melatoninergic inhibitors for acetylserotonin-O-methyltransferase using different docking routines","volume":"10","author":"Azam","year":"2013","journal-title":"Theor Biol Med Model"},{"key":"10.1016\/j.bmc.2025.118451_bb0125","first-page":"1","article-title":"Structure-based virtual screening of FDA-approved drugs to discover potential inhibitors of phosphoinositide kinase, PIKfyve","author":"Wadje","year":"2024","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.bmc.2025.118451_bb0130","doi-asserted-by":"crossref","DOI":"10.2174\/012210299X310595240626104426","article-title":"Evaluation of 3, 3\u2019-disubstituted oxindoles derivatives as a potential anti-Cancer tyrosine kinase inhibitors-molecular docking and ADME studies","volume":"2","author":"Kaur","year":"2024","journal-title":"Curr Indian Sci"},{"key":"10.1016\/j.bmc.2025.118451_bb0135","first-page":"213","article-title":"Structure-based drug design, molecular dynamics and ADME\/tox to investigate protein kinase anti-cancer agents","volume":"13","author":"Mlp Diniz","year":"2017","journal-title":"Curr Bioactive Compd"},{"key":"10.1016\/j.bmc.2025.118451_bb0140","doi-asserted-by":"crossref","unstructured":"M. Mohammed, A.A. Adnan, In-silico design, molecular docking, molecular dynamic simulations, Molecular mechanics with generalised Born and surface area solvation study, and pharmacokinetic prediction of novel diclofenac as anti-inflammatory compounds, Turkish Computat Theor Chem, 8 108\u2013121.","DOI":"10.33435\/tcandtc.1355772"},{"key":"10.1016\/j.bmc.2025.118451_bb0145","first-page":"1","article-title":"In silico prediction, molecular docking study for identification of novel nitrogen substituted benzoxazole derivative for their potential biological activity","author":"Chikhale","year":"2025","journal-title":"Chem Afr"},{"key":"10.1016\/j.bmc.2025.118451_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2021.108114","article-title":"Studies on ligand-based pharmacophore modeling approach in identifying potent future EGFR inhibitors","volume":"112","author":"Shaikh","year":"2022","journal-title":"J Mol Graph Model"},{"key":"10.1016\/j.bmc.2025.118451_bb0155","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.molstruc.2019.04.023","article-title":"E-pharmacophore modelling, virtual screening, molecular dynamics simulations and in-silico ADME analysis for identification of potential E6 inhibitors against cervical cancer","volume":"1189","author":"Kumar","year":"2019","journal-title":"J Mol Struct"},{"key":"10.1016\/j.bmc.2025.118451_bb0160","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4103\/2277-5706.241211","article-title":"Docking and molecular dynamics simulations studies of human protein kinase catalytic subunit alpha with antagonist","volume":"1","author":"Sandeep","year":"2012","journal-title":"J Clin Sci Res"},{"key":"10.1016\/j.bmc.2025.118451_bb0165","doi-asserted-by":"crossref","first-page":"17591","DOI":"10.1021\/acsomega.2c08167","article-title":"Methoxy-naphthyl-linked N-benzyl pyridinium styryls as dual cholinesterase inhibitors: design, synthesis, biological evaluation, and structure\u2013activity relationship","volume":"8","author":"Abdullaha","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.bmc.2025.118451_bb0170","series-title":"General Cytotoxicity Assessment by Means of the MTT Assay, Protocols in In Vitro Hepatocyte Research","first-page":"333","author":"Tolosa","year":"2014"},{"key":"10.1016\/j.bmc.2025.118451_bb0175","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1128\/AEM.65.8.3727-3729.1999","article-title":"The MTT [3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide] assay is a fast and reliable method for colorimetric determination of fungal cell densities","volume":"65","author":"Freimoser","year":"1999","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.bmc.2025.118451_bb0180","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202500549","article-title":"Design, synthesis, and molecular profiling of pyrimidine-furan derivatives targeting EGFRWT, EGFRT790M, and EGFRL858R\/T790M\/C797S in NSCLC: in vitro and in silico evaluation","volume":"22","author":"Pal","year":"2025","journal-title":"Chem Biodivers"},{"key":"10.1016\/j.bmc.2025.118451_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2023.116096","article-title":"2, 3, 5-triphenyl tetrazolium chloride as colorimetric indicator for drug susceptibility testing against nontuberculous mycobacteria","volume":"108","author":"de Souza","year":"2024","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.bmc.2025.118451_bb0190","series-title":"Protocols for in Vitro and in Vivo Studies","first-page":"271","article-title":"MTT assay protocol, advanced cell and molecular techniques","author":"Arunachalam","year":"2025"},{"key":"10.1016\/j.bmc.2025.118451_bb0195","first-page":"99","article-title":"Optimizing kinase assays for ultrahigh-throughput profiling using the kinase-glo plus assay","volume":"12","author":"Worzella","year":"2007","journal-title":"JALA: J Assoc Lab Automation"},{"key":"10.1016\/j.bmc.2025.118451_bb0200","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/1087057111422746","article-title":"Biosensor-based approach to the identification of protein kinase ligands with dual-site modes of action","volume":"17","author":"Navratilova","year":"2012","journal-title":"J Biomol Screen"},{"key":"10.1016\/j.bmc.2025.118451_bb0205","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1021\/jm701501x","article-title":"Naturally occurring homoisoflavonoids function as potent protein tyrosine kinase inhibitors by c-Src-based high-throughput screening","volume":"51","author":"Lin","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118451_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1752-153X-6-139","article-title":"Development and experimental test of support vector machines virtual screening method for searching Src inhibitors from large compound libraries","volume":"6","author":"Han","year":"2012","journal-title":"Chem Central J"},{"key":"10.1016\/j.bmc.2025.118451_bb0215","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.4014\/jmb.1710.10029","article-title":"Reactive oxygen species depletion by silibinin stimulates apoptosis-like death in Escherichia coli","volume":"27","author":"Lee","year":"2017","journal-title":"J Microbiol Biotechnol"},{"key":"10.1016\/j.bmc.2025.118451_bb0220","series-title":"Novel podophyllotoxin derivative exerts effects of an anti-cancer drug and a radiosensitizer","author":"Kwon","year":"2025"},{"key":"10.1016\/j.bmc.2025.118451_bb0225","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.3390\/nu14081620","article-title":"Geraniol ameliorates doxorubicin-mediated kidney injury through alteration of antioxidant status, inflammation, and apoptosis: potential roles of NF-\u03baB and Nrf2\/Ho-1","volume":"14","author":"AlAsmari","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.bmc.2025.118451_bb0230","series-title":"Quantitation of Apoptosis and Necrosis by Annexin V Binding, Propidium Iodide Uptake, and Flow Cytometry","author":"Crowley","year":"2016"},{"key":"10.1016\/j.bmc.2025.118451_bb0235","doi-asserted-by":"crossref","first-page":"e374","DOI":"10.21769\/BioProtoc.374","article-title":"Protocol for apoptosis assay by flow cytometry using annexin V staining method","volume":"3","author":"Lakshmanan","year":"2013","journal-title":"Bio-protocol"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096808962500392X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096808962500392X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:58:55Z","timestamp":1780635535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096808962500392X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":47,"alternative-id":["S096808962500392X"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118451","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacophore-based high-throughput virtual screening (HTVS) to identify new c-Src kinase inhibitors with anticancer potential","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118451","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118451"}}